Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implications.
about
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsSerum levels of angiopoietin-2 are associated with the growth of multiple myelomaDownregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cellsBilateral proliferative retinopathy as the initial presentation of chronic myeloid leukemia.Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1-independent disease progression.Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.A case of leukemic retinopathy mimicking common ischemic retinopathies.Leucapheresis for management of retinopathy in chronic myeloid leukaemia.Elevated plasma levels of vascular endothelial growth factor is associated with marked splenomegaly in chronic myeloid leukemia.Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.The underestimated role of basophils in Ph chronic myeloid leukaemia
P2860
Q26778929-09FEBB0D-E53D-4409-96AF-CC53A522C341Q28292520-448974E7-DFEE-4FD4-B83B-053F1D6C2850Q31055456-B1C341C6-0A56-4DC3-99B0-D4268DF0C96DQ35067124-F045B01A-25F8-4B73-8991-3EE866816DFFQ35608487-EF683BAA-33AB-45D9-8743-8476567F5175Q39294830-7FE9624F-56DC-4E96-80D4-257F279C31E9Q40420700-7C15BCA2-D0A2-4E38-9320-C5221C69BE87Q42543085-7640DB4D-81B8-44CA-8C75-3366EBF614F7Q46191897-A047C1DA-4836-406E-8B4A-746CE9E6752DQ46786377-450A9B8B-FE46-439D-AF0F-5F06433563B6Q46882251-B2697E33-2095-4B95-8A24-CD1F3BDBF2C4Q58798189-42DACB8A-3E77-425D-A31A-30C475E79AFF
P2860
Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Expression of angiogenic facto ...... tential clinical implications.
@ast
Expression of angiogenic facto ...... tential clinical implications.
@en
type
label
Expression of angiogenic facto ...... tential clinical implications.
@ast
Expression of angiogenic facto ...... tential clinical implications.
@en
prefLabel
Expression of angiogenic facto ...... tential clinical implications.
@ast
Expression of angiogenic facto ...... tential clinical implications.
@en
P2093
P2860
P1476
Expression of angiogenic facto ...... tential clinical implications.
@en
P2093
Aichberger KJ
Mayerhofer M
Sillaber C
P2860
P356
10.1111/J.0960-135X.2004.01365.X
P478
34 Suppl 2
P577
2004-08-01T00:00:00Z